Intuitive Surgical, Inc. $ISRG Shares Sold by J. Safra Sarasin Holding AG

J. Safra Sarasin Holding AG decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 38.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,222 shares of the medical equipment provider’s stock after selling 17,108 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Intuitive Surgical were worth $12,174,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in ISRG. Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after buying an additional 670,302 shares in the last quarter. State Street Corp boosted its holdings in Intuitive Surgical by 1.2% in the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after purchasing an additional 182,871 shares during the last quarter. Geode Capital Management LLC grew its stake in Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock valued at $4,429,590,000 after purchasing an additional 109,904 shares in the last quarter. Norges Bank purchased a new stake in Intuitive Surgical during the 2nd quarter worth approximately $2,569,260,000. Finally, Invesco Ltd. raised its position in shares of Intuitive Surgical by 4.8% in the 2nd quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock valued at $2,402,488,000 after purchasing an additional 201,159 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on ISRG. Citigroup restated a “neutral” rating and issued a $590.00 price target (down previously from $635.00) on shares of Intuitive Surgical in a research note on Friday. Daiwa Capital Markets raised their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research note on Thursday, October 23rd. Sanford C. Bernstein increased their price target on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $620.41.

Insider Activity at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 3,500 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president owned 5,758 shares in the company, valued at approximately $3,310,850. This represents a 37.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 22,806 shares of Intuitive Surgical stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the completion of the sale, the insider owned 2,694 shares in the company, valued at approximately $1,537,977.66. This represents a 89.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 48,152 shares of company stock valued at $27,470,571. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 0.9%

Shares of ISRG stock opened at $528.81 on Tuesday. The company has a market cap of $189.57 billion, a P/E ratio of 67.02, a PEG ratio of 4.26 and a beta of 1.67. The business has a 50 day moving average of $561.96 and a two-hundred day moving average of $511.58. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s revenue was up 18.8% on a year-over-year basis. During the same quarter last year, the business posted $2.21 EPS. Analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.